Medical isotope production without highly enriched uranium

"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the m...

Full description

Bibliographic Details
Corporate Author: National Research Council (U.S.). Committee on Medical Isotope Production Without Highly Enriched Uranium.
Format: Electronic
Language:English
Published: Washington, D.C. : National Academies Press, c2009.
Subjects:
Online Access:ebrary
View fulltext via EzAccess
MyiLibrary
https://ezaccess.library.uitm.edu.my/login?url=http://site.ebrary.com/lib/alltitles/Doc?id=10315882
LEADER 05297cam a2200805Ia 4500
001 2429
003 OCoLC
005 20130711001639.0
006 m o d
007 cr mnu---uuuuu
008 090601s2009 dcua obt 000 0 eng d
019 # # |a 435620120  |a 549601756  |a 646813759  |a 656456525  |a 666970549 
020 # # |a 9780309130400 (electronic bk.) 
020 # # |a 0309130409 (electronic bk.) 
020 # # |z 9780309130394 (pbk.) 
020 # # |z 0309130395 (pbk.) 
024 8 # |a 9786612239243 
029 1 # |a CDX  |b 10560293 
029 1 # |a NZ1  |b 13242019 
029 1 # |a DEBSZ  |b 372812708 
029 1 # |a AU@  |b 000051503378 
035 # # |a (OCoLC)367597412 
037 # # |a 223924  |b MIL 
040 # # |a MMU  |b eng  |c MMU  |d CDX  |d N$T  |d IDEBK  |d OCLCQ  |d QE2  |d E7B  |d CNCGM  |d OCLCQ  |d WVH  |d OCLCQ  |d TCO  |d MYPMP  |d OCLCQ  |d DEBSZ  |d YDXCP 
043 # # |a n-us--- 
049 # # |a MYTA 
050 # 4 |a QD181.U7  |b N385 2009eb 
060 # 4 |a 2009 I-388 
060 # 4 |a WN 420  |b N278m 2009 
072 # 7 |a POL  |x 017000  |2 bisacsh 
082 0 4 |a 353.008722  |2 22 
245 0 0 |a Medical isotope production without highly enriched uranium  |c Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies.  |h [electronic resource] / 
260 # # |a Washington, D.C. :  |b National Academies Press,  |c c2009. 
300 # # |a 1 online resource (xviii, 202 p.) 
500 # # |a Title from electronic title page (viewed June 1, 2009). 
504 # # |a Includes bibliographical references. 
505 0 # |a Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility. 
520 # # |a "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply." 
536 # # |a Sponsored by the National Academy of Sciences and the U.S. Department of Energy  |c DE-AM01-04PI45013 
650 # 0 |a Uranium  |x Isotopes. 
650 # 0 |a Uranium  |x Isotopes  |x Therapeutic use. 
650 # 0 |a Highly enriched uranium  |x Isotopes  |x Therapeutic use. 
650 # 0 |a Molybdenum  |x Isotopes  |x Therapeutic use. 
650 # 0 |a Technetium  |x Isotopes  |x Therapeutic use. 
650 # 0 |a Radioisotopes  |x Therapeutic use. 
650 # 0 |a Nuclear medicine  |x Standards  |z United States. 
650 1 2 |a Molybdenum  |x supply & distribution  |z United States. 
650 1 2 |a Nuclear Medicine  |x standards  |z United States. 
650 2 2 |a Molybedenum  |x isolation & purification  |z United States. 
650 2 2 |a Radioisotopes  |x supply & distribution  |z United States. 
650 2 2 |a Technetium Compounds  |x isolation & purification  |z United States. 
650 2 2 |a Diagnostic Imaging  |z United States. 
650 2 2 |a Radionuclide Generators  |z United States. 
650 2 2 |a Quality Control  |z United States. 
650 # 7 |a POLITICAL SCIENCE  |x Public Affairs & Administration.  |2 bisacsh 
655 # 2 |a Electronic Books. 
655 # 4 |a Electronic books. 
655 # 0 |a Electronic books. 
710 2 # |a National Research Council (U.S.).  |b Committee on Medical Isotope Production Without Highly Enriched Uranium. 
776 0 8 |d Washington, D.C. : National Academies Press, c2009  |i Print version:  |w (OCoLC)310392635 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://site.ebrary.com/id/10315882  |3 ebrary 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=285289  |z View fulltext via EzAccess 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://www.myilibrary.com?id=223924  |3 MyiLibrary 
856 4 # |u https://ezaccess.library.uitm.edu.my/login?url=http://site.ebrary.com/lib/alltitles/Doc?id=10315882  |x Aggregator 
938 # # |a Coutts Information Services  |b COUT  |n 10560293 
938 # # |a ebrary  |b EBRY  |n ebr10315882 
938 # # |a Ingram Digital eBook Collection  |b IDEB  |n 223924 
938 # # |a EBSCOhost  |b EBSC  |n 285289 
938 # # |a YBP Library Services  |b YANK  |n 3093613 
999 # # |z 635090427501196915